shuttle, fructose and mannose degradation and mitochondrial electron transport chain were the most significant (p<0.05). CONCLUSIONS: Our study, revealed, for the first time, a specific metabolic profile associated to MSK and confirmed our previous published evidences that this cystic disease could be characterized by additional systemic biochemical alterations (including mitochondrial dysfunction and alterations of the sphingomyelin metabolism). Finally, in future, some identified metabolic factors could represent new diagnostic biomarkers employable in the "day by day" clinical practice.
INTRODUCTION AND AIMS:
Endothelial dysfunction leading to unbalanced vasoconstriction and ischemia of renal parenchyma is increasingly proposed as an additional pathway of renal damage in autosomal-dominant-polycystic-kidney-disease (ADPKD). However, human studies investigating the evolution of such phenomena are limited. This study investigated the levels of emerging biomarkers of endothelial function, angiogenesis and hypoxia, in ADPKD patients with different renal function. METHODS: The study population consisted of three groups: 26 ADPKD patients with impaired renal function (Group A) (eGFR 45-70 ml/min/1.73m 2 ), 26 ADPKD patients with preserved renal function (Group B) (eGFR >70 ml/min/1.73m 2 ), and 26 age-and sex-matched controls with no history of renal disease. Circulating levels of endocan (endothelial cell-specific molecule-1) angiopoietin-2, and hypoxia-induced-factor-1a (HIF-1a) were determined by ELISA techniques. RESULTS: Patients in Group A had significantly higher levels of endocan (7.1760.43 ng/ml), angiopoietin-2 (5,595.4363,390) and .84 pg/ml) compared to patients in Group B (6.8660.59 ng/ml, p¼0.017, 3, 854.4163, 014.30, p¼0.018, 136.84642 .10 pg/ml, p¼0.019, respectively) or controls (4.8360.69 ng/ml, 1,0696427.88 pg/ml, 70.20617.49 pg/ml, p<0.001 for all comparisons). Of note, patients in Group B had also higher levels of all markers compared to controls (p<0.001), despite having similar renal function. In correlation analyses within ADPKD patients, we noted strong correlations of all studied markers with ADMA (endocan r¼0.908,p<0.001, angiopoietin2 r¼0.983,p<0.001 and HIF-1a r¼0.998,p<0.001), and only weak or modest correlations with eGFR. CONCLUSIONS: In conclusion, this study suggests that not only patients with low eGFR, but also those at early stages of the ADPKD had higher expression of markers indicative for endothelial dysfunction, angiogenesis and hypoxia in comparison to controls. These results could lead to the hypothesis that local microcirculatory changes may come early in the course of ADPKD and could be a cause rather than a result of disease progression and eGFR decline. Vasopressin suppression through high water intake represents a rational but unproven alternative to pharmacological vasopressin blockade. Therefore, ADPKD patients are commonly advised to maintain high-water intake. METHODS: Given that a low urine specific gravity (uSG) may provide a surrogate for Vasopressin suppression, we examined the effect of generic high-water intake advice on uSG in a single center retrospective cohort study of incident ADPKD patients with longitudinal follow-up data presenting between 2010 and 2015 to a tertiary renal genetics service. Since standardized hydration advice was introduced in 2013, we compared change in uSG in those presenting before (NH) versus after (H) the introduction of such advice. RESULTS: Data were available for 76 patients, with median age of 43 (IQR 32-56) years. Thirty-nine (59%) were female, 64 (84%) were Caucasian, 37 (49%) had a PKD1 mutation, and 42 (55%) were on anti-hypertensives. The median creatinine was 85 (IQR 68-118) lmol/L and the mean eGFR was 75 (SD 24) ml/min/1.73m 2 . Mean arterial pressure was 101 (SD 12) mmHg. 38% (29) had large kidneys (length more than or equal to 16 cm, Total Kidney Volume more than or equal to 750mls). There was no significant difference in baseline characteristics between NH and H groups. Baseline uSG in the NH group (1.015 IQR 1.010-1.020) and H group (1.015, IQR 1.015-1.020) did not change during follow up (1.015, IQR 1.010-1.020, p¼0.308 and 1.020 IQR 1.015-1.025, p¼0.375 respectively) Figure 1 . In an ordered logistic regression model adjusted for ethnic origin, age, gender, eGFR, presence of haematuria and proteinuria, as well as the use of renin angiotensin inhibitors and diuretics, proteinuria (OR 36.72, p¼0 .000) predicted a higher baseline uSG, while non-white ethnic origin (OR 0.12, 95%CI 0.02-0.88, p¼0.037) and taking renin-angiotensin inhibitors (OR 0.31, 95%CI 0.10-0.96, p¼0.043) predicted lower baseline uSG. CONCLUSIONS: Hydration advice embedded in routine clinical practice does not affect uSG. This may reflect limitations of uSG as a surrogate for vasopressin suppression, but may also indicate additional compliance-enhancing strategies may be required to ensure sufficient adherence to recommended fluid intake to be of clinical benefit.
FP060 MORNING BLOOD PRESSURE SURGE IN EARLY AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE AND ITS RELATION WITH LEFT VENTRICULAR HYPERTROPHY
Abdü lmecit Yıldız 6 , Saim Sag 2 , Cuma Gul 1 , Fatma Can 4 , Ays¸egü l Oruc 6 , Mehmet Aydın 3 , € Omer Bedir 5 , Suat Akgü r 6 , Yavuz Ayar 6 , Sü meyye Gü llü lü 5 , Mustafa Gü llü lü 6 , Alparslan Ersoy 6 INTRODUCTION AND AIMS: Left ventricular hypertrophy and endotehelial dysfunction (ED) are well recognized, but poorly understood cardiovascular abnormality in early Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients. We studied the association between the Morning Blood Pressure surge (MBPS) and these CV abnormalities in early ADPKD METHODS: Fifty-eight patients with ADPKD having well-preserved renal function and 45 healthy control were included in the study. Ambulatory blood pressure monitoring was performed and MBPS was calculated. The patients and control groups were categorized according to MBPS as MBPS (þ) and MBPS (-). Left ventricular mass index (LVMI), left ventricular geometry were evaluated by echocardiography and endothelialdependent dilatation (FMD%), carotid intima media thickness (CIMT, mm) by high-resolution vascular ultrasound. Findings were compared between groups. RESULTS: Age and gender distribution were similar between patients and controls (44613 vs 43612, p¼0.839 and 19/26 vs 31/27 p¼0.176, respectively). The mean GFR (CKD-EPI) was lower in ADPKD (99620 vs 110616, p¼0.003). The LVMI and CIMT were significantly higher in patients with ADPKD (108625 vs 94620, p¼0.003 and 6.862.3 vs 361.1, p<0.001, respectively).There was a significant positive correlation between MBPS and LVMI in ADPKD group but not in controls (figure).FMD% was significantly diminished in ADPKD (16.666.4 vs 16.666.4, p¼0.001) . In ADPKD group, the LVMI, CIMT, hsCRP, spot microalbuminuria were significantly higher in MBPS (þ) cases than MBPS (-) cases. However, there were no significant differences in 
